Nukkleus Ebitda from 2010 to 2024

NUKKW Stock   0.01  0.02  67.11%   
Nukkleus EBITDA yearly trend continues to be fairly stable with very little volatility. EBITDA is likely to outpace its year average in 2024. During the period from 2010 to 2024, Nukkleus EBITDA regression line of quarterly data had r-squared of  0.33 and coefficient of variation of (170.44). View All Fundamentals
 
EBITDA  
First Reported
2013-09-30
Previous Quarter
-2.4 M
Current Value
-1.4 M
Quarterly Volatility
1.7 M
 
Yuan Drop
 
Covid
Check Nukkleus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nukkleus' main balance sheet or income statement drivers, such as Depreciation And Amortization of 183.4 K, Selling General Administrative of 3.4 M or Selling And Marketing Expenses of 55.8 K, as well as many indicators such as Price To Sales Ratio of 45.05, Ptb Ratio of 51.21 or Capex To Depreciation of 0.0. Nukkleus financial statements analysis is a perfect complement when working with Nukkleus Valuation or Volatility modules.
  
Check out the analysis of Nukkleus Correlation against competitors.
For more information on how to buy Nukkleus Stock please use our How to Invest in Nukkleus guide.

Latest Nukkleus' Ebitda Growth Pattern

Below is the plot of the Ebitda of Nukkleus over the last few years. It is Nukkleus' EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nukkleus' overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

Nukkleus Ebitda Regression Statistics

Arithmetic Mean(734,186)
Coefficient Of Variation(170.44)
Mean Deviation803,009
Median(176,801)
Standard Deviation1,251,354
Sample Variance1.6T
Range4.8M
R-Value(0.57)
Mean Square Error1.1T
R-Squared0.33
Significance0.03
Slope(160,014)
Total Sum of Squares21.9T

Nukkleus Ebitda History

2024-1.3 M
2023-1.3 M
2022-1.5 M
2021-4.8 M
2020-463.1 K
2019-113.1 K
2018-715.8 K

About Nukkleus Financial Statements

Nukkleus investors use historical fundamental indicators, such as Nukkleus' Ebitda, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Nukkleus. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBITDA-1.3 M-1.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Nukkleus Stock Analysis

When running Nukkleus' price analysis, check to measure Nukkleus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nukkleus is operating at the current time. Most of Nukkleus' value examination focuses on studying past and present price action to predict the probability of Nukkleus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nukkleus' price. Additionally, you may evaluate how the addition of Nukkleus to your portfolios can decrease your overall portfolio volatility.